| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Limberg MB | |
| P433 | issue | 4 Suppl | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2S-9S | |
| P577 | publication date | 1991-10-01 | |
| P1433 | published in | American Journal of Ophthalmology | Q4744258 |
| P1476 | title | A review of bacterial keratitis and bacterial conjunctivitis | |
| P478 | volume | 112 |
| Q35783119 | 2-O-Sulfated Domains in Syndecan-1 Heparan Sulfate Inhibit Neutrophil Cathelicidin and Promote Staphylococcus aureus Corneal Infection |
| Q40311382 | A Mouse Model for Ocular Surface Staphylococcus aureus Infection |
| Q37677582 | Acute infectious conjunctivitis in childhood. |
| Q26823285 | Bacterial conjunctivitis |
| Q84478494 | Bacterial conjunctivitis |
| Q28367727 | Bacterial keratitis: a prospective clinical and microbiological study |
| Q35782676 | Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis |
| Q37221592 | Distribution of bacterial keratitis and emerging resistance to antibiotics in China from 2001 to 2004. |
| Q35069760 | Molecular epidemiology of clinical and carrier strains of methicillin resistant Staphylococcus aureus (MRSA) in the hospital settings of north India |
| Q92697078 | Nine-year analysis of isolated pathogens and antibiotic susceptibilities of microbial keratitis from a large referral eye center in southern China |
| Q41024651 | Pharmacokinetic considerations in the treatment of bacterial keratitis |
| Q36220338 | Role of glycosaminoglycans in infectious disease |
| Q36802608 | Role of heparan sulfate in ocular diseases. |
| Q35591453 | Severe infective keratitis leading to hospital admission in New Zealand |
| Q35156428 | Simplifying collection of corneal specimens in cases of suspected bacterial keratitis. |
| Q38784468 | Staphylococcus aureus lipoproteins trigger human corneal epithelial innate response through toll-like receptor-2 |
| Q34536823 | Syndecan-1 promotes Staphylococcus aureus corneal infection by counteracting neutrophil-mediated host defense |
| Q39747466 | The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis |
| Q39250232 | Therapy-resistant purulent keratoconjunctivitis |
Search more.